REN and Myocardial fibrosis: 2) the use of inhibitors of the renin-angiotensin-aldosterone system such as angiotensin converting enzyme inhibitors, angiotensin receptor blockers (ARB) and mineralocorticoid receptor antagonists (MRA) which are known potent inhibitors of myocardial fibrosis [57–60].